![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
New Monogram HCV Protease Inhibitor Resistance Test: "Cross-sectional Assessment of 1500 Clinical Samples Submitted for HCV NS3/4A Protease Inhibitor Drug Resistance Testing in the US"
|
|
|
Reported by Jules Levin, AASLD Washington, DC, November 1-5, 2013
Sunny S. Choe, Joseph M. Volpe, Jacqueline D. Reeves, Wei Huang, Mojgan Haddad, Christos J. Petropoulos, and Charles M. Walworth*
Monogram Biosciences, Inc. South San Francisco, CA, USA
New Protease Inhibitor (NS3/4A) Drug Resistance Test
http://www.natap.org/2011/HCV/080611_01.htm
LabCorp Introduces HCV Resistance Testing Through Monogram Biosciences With The Launch Of HCV GenoSure® NS3/4A
http://www.natap.org/2011/newsUpdates/090811_13.htm
AASLD/2011: Validation of an HCV NS3/4A Sequencing Assay for Evaluating Resistance to Boceprevir, Telaprevir and Protease Inhibitor Candidates in a Clinical Reference Laboratory Setting - (12/08/11)
![AASLD1.gif](../images/120413/120413-4/AASLD1.gif)
![AASLD2.gif](../images/120413/120413-4/AASLD2.gif)
![AASLD3.gif](../images/120413/120413-4/AASLD3.gif)
![AASLD4.gif](../images/120413/120413-4/AASLD4.gif)
![AASLD5.gif](../images/120413/120413-4/AASLD5.gif)
![AASLD6.gif](../images/120413/120413-4/AASLD6.gif)
![AASLD7.gif](../images/120413/120413-4/AASLD7.gif)
![AASLD8.gif](../images/120413/120413-4/AASLD8.gif)
![AASLD9.gif](../images/120413/120413-4/AASLD9.gif)
![AASLD10.gif](../images/120413/120413-4/AASLD10.gif)
![AASLD11.gif](../images/120413/120413-4/AASLD11.gif)
![AASLD12.gif](../images/120413/120413-4/AASLD12.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|